checkAd

     101  0 Kommentare Addus HomeCare Announces Fourth Quarter and Year End 2023 Financial Results

    Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2023.

    Fourth Quarter 2023 Highlights:

    • Net Service Revenues Grow 11.9% to $276.4 Million
    • Net Income of $19.6 Million, or $1.20 per Diluted Share
    • Adjusted Net Income per Diluted Share Increases 18.9% year-over-year to $1.32
    • Adjusted EBITDA Increases 21.3% year-over-year to $34.3 Million
    • Cash Flow from Operations of $30.0 Million

    Overview

    Net service revenues were $276.4 million for the fourth quarter of 2023, an 11.9% increase compared with $247.1 million for the fourth quarter of 2022. Net income was $19.6 million for the fourth quarter of 2023, compared with $14.8 million for the fourth quarter of 2022, while net income per diluted share was $1.20 compared with $0.91 for the same period a year ago. Adjusted EBITDA increased 21.3% to $34.3 million for the fourth quarter of 2023 from $28.2 million for the fourth quarter of 2022. Adjusted net income was $21.6 million for the fourth quarter of 2023 compared with $18.1 million for the prior-year period, while adjusted net income per diluted share was $1.32 compared with $1.11 for the fourth quarter of 2022. Adjusted net income per diluted share for the fourth quarter of 2023 excludes the positive impact of retroactive collective bargaining negotiations of $(0.07), acquisition expenses of $0.07 and stock-based compensation expense of $0.12 (See the end of press release for a reconciliation of all non-GAAP and GAAP financial measures.)

    For 2023, net service revenues increased 11.3% to $1.06 billion from $951.1 million for the prior-year period. Net income was $62.5 million for 2023 compared with $46.0 million for 2022, and net income per diluted share was $3.83 compared with $2.84 per diluted share. Adjusted EBITDA increased 19.3% to $121.0 million for 2023 from $101.5 million for 2022. Adjusted net income was $74.8 million for 2023 compared with $60.3 million for 2022, while adjusted net income per diluted share was $4.58 compared with $3.73 for the prior-year period.

    Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, “Our fourth quarter financial and operating performance marked a strong finish to another record year for Addus. Revenue was up 11.9% and adjusted EBITDA was 21.3% higher for the fourth quarter of 2023 compared with the same period last year. Propelled by the strong momentum in our business throughout 2023, we surpassed $1.0 billion in annual revenues for the first time.

    “We continued to benefit from robust demand for home-based care, especially for our personal care services, which accounted for 74.0% of our revenues. We were pleased with our 11.2% organic revenue growth on a same store basis for the quarter, and our annual growth rate of 12.1% was a record for our personal care services. This impressive revenue growth reflects higher volumes, as well as continued rate support for our services.

    “Our fourth quarter results included a full three months of operations from Tennessee Quality Care, a provider of home health, hospice, and private duty nursing services, which we acquired August 1, 2023. These acquired operations allowed us to expand our coverage capabilities to all three levels of home-based care in Tennessee, and we are excited about the opportunities to serve more patients in this strategically important market. We will continue to identify additional markets where we can enhance our personal care presence and add clinical care operations, especially where we see potential for growth in value-based contracting models, as payors have expressed interest in both the cost benefits and high quality of our home-based care services.

    “Hospice services accounted for 19.8% of revenue for the fourth quarter and included the benefit of a 3.1% rate increase that was effective on October 1, 2023. Hospice revenues were up 3.5% over the fourth quarter of 2022 on a same-store basis, and we were pleased to see further improvement in average daily census and length of stay compared with the same period last year,” said Allison.

    Cash and Liquidity

    As of December 31, 2023, the Company had cash of $64.8 million and bank debt of $126.4 million, with capacity and availability under its revolving credit facility of $470.0 million and $335.6 million, respectively. Net cash provided by operating activities was $30.0 million for the fourth quarter of 2023, and $112.2 million for the full year 2023, inclusive of a net $7.6 million in ARPA funds utilization.

    Allison added, “In 2023 we generated strong cash flow from operations, bolstered by higher revenues and consistent payments from our various payors. Combined with our disciplined balance sheet management, we were able to fully fund our acquisitions during 2023 and still lower our revolver balance by $8.5 million from the end of the prior year. Importantly, we have the financial flexibility to continue to invest in our business and pursue our strategic growth initiatives, including acquisitions and other potential development opportunities. We are optimistic that we will see attractive acquisition opportunities in 2024 as market conditions continue to improve.

    “As we look to 2024, we will continue to build on our momentum and capitalize on the growing demand for our home-based care. Addus offers a strong value proposition with high-quality and cost-effective care for patients in the preferred home setting. We are fortunate to have a dedicated team of caregivers across our markets who advance our mission to provide outstanding care and support for increasing numbers of patients and families. We continue to look for ways to improve the way we deliver care with enhanced training and investments in applications that support our caregivers with more efficient scheduling and overall service. With this capable team representing Addus, we are confident in our ability to extend our market reach in 2024 and deliver greater value to our shareholders.”

    Non-GAAP Financial Measures

    The information provided in this release includes adjusted net income, adjusted EBITDA, adjusted net income per diluted share and adjusted net service revenue, which are non-GAAP financial measures. The Company defines adjusted net income as net income before acquisition expenses, stock-based compensation expenses, restructure and other non-recurring costs, gain or loss on the sale of assets, retroactive rate increases from New York, and the retroactive impact from collective bargaining negotiations. The Company defines adjusted EBITDA as earnings before interest expense, other non-operating income, taxes, depreciation, amortization, acquisition expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, retroactive rate increases from New York, and the retroactive impact from collective bargaining negotiations. The Company defines adjusted net income per diluted share as net income per share, adjusted for acquisition expenses, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, retroactive rate increases from New York, and the retroactive impact from collective bargaining negotiations. The Company defines adjusted net service revenues as revenue adjusted for the closure of certain sites. The Company has provided, in the financial statement tables included in this press release, a reconciliation of adjusted net income to net income, a reconciliation of adjusted EBITDA to net income, a reconciliation of adjusted diluted net income per share to net income per share, and a reconciliation of adjusted net service revenues to net service revenues, in each case, the most directly comparable GAAP measure. Management believes that adjusted net income, adjusted EBITDA, adjusted diluted net income per share, and adjusted net service revenues are useful to investors, management and others in evaluating the Company’s operating performance, to provide investors with insight and consistency in the Company’s financial reporting and to present a basis for comparison of the Company’s business operations among periods, and to facilitate comparison with the results of the Company’s peers.

    Conference Call

    Addus will host a conference call on Tuesday, February 27, 2024, at 9:00 a.m. Eastern time. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on March 5, 2024, by dialing (877) 344-7529 (international dial-in number is (412) 317-0088) and entering pass code 1856114.

    A live broadcast of Addus HomeCare’s conference call will be available under the Investor Relations section of the Company’s website: www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately two hours following the conclusion of the live broadcast.

    Forward-Looking Statements

    Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as “preliminary,” “continue,” “expect,” and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare’s relationships with referral sources, increased competition for Addus HomeCare’s services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, any security breaches, cyber-attacks, loss of data or cybersecurity threats or incidents, and other risks set forth in the Risk Factors section in Addus HomeCare’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 28, 2023, which is available at www.sec.gov. The financial information described herein and the periods to which they relate are preliminary estimates that are subject to change and finalization. There is no assurance that the final amounts and adjustments will not differ materially from the amounts described above, or that additional adjustments will not be identified, the impact of which may be material. Addus HomeCare undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties, and other factors. Accordingly, any forward-looking statements included in this press release do not purport to be predictions of future events or circumstances and may not be realized. (Unaudited tables and notes follow).

    About Addus HomeCare

    Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare’s consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare’s payor clients include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to over 49,000 consumers through 217 locations across 22 states. For more information, please visit www.addus.com.

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
    Condensed Consolidated Statements of Income
    (amounts and shares in thousands, except per share data)
    (Unaudited)
     
    Income Statement Information:

    For the Three Months
    Ended December 31,

     

    For the Twelve Months
    Ended December 31,

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

     
    Net service revenues

    $

    276,351

     

    $

    247,050

     

    $

    1,058,651

     

    $

    951,120

     

    Cost of service revenues

     

    183,938

     

     

    168,281

     

     

    718,775

     

     

    651,381

     

     
    Gross profit

     

    92,413

     

     

    78,769

     

     

    339,876

     

     

    299,739

     

     

    33.4

    %

     

    31.9

    %

     

    32.1

    %

     

    31.5

    %

    General and administrative expenses

     

    60,766

     

     

    54,466

     

     

    234,794

     

     

    216,942

     

    Depreciation and amortization

     

    3,677

     

     

    3,489

     

     

    14,126

     

     

    14,060

     

    Total operating expenses

     

    64,443

     

     

    57,955

     

     

    248,920

     

     

    231,002

     

     
    Operating income

     

    27,970

     

     

    20,814

     

     

    90,956

     

     

    68,737

     

     
    Total interest expense, net

     

    2,616

     

     

    2,537

     

     

    9,630

     

     

    8,566

     

     
    Income before income taxes

     

    25,354

     

     

    18,277

     

     

    81,326

     

     

    60,171

     

    Income tax expense

     

    5,776

     

     

    3,515

     

     

    18,810

     

     

    14,146

     

     
    Net income

    $

    19,578

     

    $

    14,762

     

    $

    62,516

     

    $

    46,025

     

     
    Net income per diluted share:

    $

    1.20

     

    $

    0.91

     

    $

    3.83

     

    $

    2.84

     

     
     
    Weighted average number of common shares outstanding:
    Diluted

     

    16,307

     

     

    16,258

     

     

    16,311

     

     

    16,181

     

     
     
     
     
    Cash Flow Information:

    For the Three Months
    Ended December 31,

     

    For the Twelve Months
    Ended December 31,

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

     
    Net cash provided by operating activities

    $

    30,049

     

    $

    24,292

     

    $

    112,247

     

    $

    105,110

     

    Net cash (used in) investing activities

     

    (5,302

    )

     

    (19,236

    )

     

    (119,236

    )

     

    (106,590

    )

    Net cash (used in) financing activities

     

    (39,706

    )

     

    (30,739

    )

     

    (8,181

    )

     

    (87,454

    )

     
    Net change in cash

     

    (14,959

    )

     

    (25,683

    )

     

    (15,170

    )

     

    (88,934

    )

    Cash at the beginning of the period

     

    79,750

     

     

    105,644

     

     

    79,961

     

     

    168,895

     

    Cash at the end of the period

    $

    64,791

     

    $

    79,961

     

    $

    64,791

     

    $

    79,961

     

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
    Condensed Consolidated Balance Sheets
    (Amounts in thousands)
    (Unaudited)
       
       
       

    December 31,

     

    2023

     

     

     

    2022

     
    Assets  
       
    Current assets  
    Cash

    $

    64,791

     

    $

    79,961

    Accounts receivable, net

     

    115,499

     

     

    125,501

    Prepaid expenses and other current assets

     

    19,714

     

     

    17,345

       
    Total current assets

     

    200,004

     

     

    222,807

       
    Property and equipment, net

     

    24,011

     

     

    21,182

       
    Other assets  
    Goodwill

     

    662,995

     

     

    582,837

    Intangible assets, net

     

    91,983

     

     

    72,188

    Operating lease assets

     

    45,433

     

     

    38,980

    Total other assets

     

    800,411

     

     

    694,005

       
    Total assets

    $

    1,024,426

     

    $

    937,994

       
    Liabilities and stockholders' equity  
       
    Current liabilities  
    Accounts payable

    $

    26,183

     

    $

    22,092

    Accrued payroll

     

    56,551

     

     

    44,937

    Accrued expenses

     

    33,236

     

     

    27,507

    Operating lease liabilities - current portion

     

    11,339

     

     

    10,801

    Government stimulus advance

     

    5,765

     

     

    12,912

    Accrued workers compensation

     

    12,043

     

     

    12,897

    Total current liabilities

     

    145,117

     

     

    131,146

       
    Long-term debt, less current portion, net of debt issuance costs

     

    124,132

     

     

    131,772

    Long-term lease liability, less current portion

     

    39,711

     

     

    35,479

    Other long-term liabilities

     

    8,772

     

     

    6,057

    Total long-term liabilities

     

    172,615

     

     

    173,308

       
    Total liabilities

     

    317,732

     

     

    304,454

       
    Total stockholders' equity

     

    706,694

     

     

    633,540

       
    Total liabilities and stockholders' equity

    $

    1,024,426

     

    $

    937,994

    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
    Net Service Revenue by Segment
    (Amounts in thousands)
    (Unaudited)
     

    For the Three Months
    Ended December 31,

     

    For the Twelve Months
    Ended December 31,

     

    2023

     

     

    2022

     

     

    2023

     

     

    2022

    Net Service Revenues by Segment
     
    Personal Care

    $

    204,491

    $

    183,365

    $

    794,718

    $

    706,507

    Hospice

     

    54,741

     

    50,612

     

    207,155

     

    201,772

    Home Health

     

    17,119

     

    13,073

     

    56,778

     

    42,841

    Total Revenue

    $

    276,351

    $

    247,050

    $

    1,058,651

    $

    951,120

     
    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
    Key Statistical and Financial Data (Unaudited)
       

    For the Three Months
    Ended December 31,

     

    For the Twelve Months
    Ended December 31,

     

    2023

     

     

    2022

     

     

     

    2023

     

     

    2022

       
       
    Personal Care  
       
    States served at period end

     

    -

     

     

    -

     

     

     

    21

     

     

    21

    Locations at period end

     

    -

     

     

    -

     

     

     

    156

     

     

    156

    Average billable census - same store (1)

     

    37,993

     

     

    38,169

     

     

     

    38,430

     

     

    37,482

    Average billable census - acquisitions

     

    85

     

     

    -

     

     

     

    91

     

     

    -

    Average billable census total

     

    38,078

     

     

    38,169

     

     

     

    38,521

     

     

    37,482

    Billable hours (in thousands)

     

    7,694

     

     

    7,465

     

     

     

    30,658

     

     

    29,412

    Average billable hours per census per month

     

    67.2

     

     

    65.0

     

     

     

    66.2

     

     

    65.1

    Billable hours per business day

     

    118,366

     

     

    114,849

     

     

     

    117,915

     

     

    113,122

    Revenues per billable hour

    $

    26.53

     

    $

    24.48

     

     

    $

    25.86

     

    $

    23.91

    Organic growth  
    - Revenue

     

    11.2

    %

     

    7.9

    %

     

     

    12.1

    %

     

    4.6

    %

       
    Hospice  
       
    Locations served at period end

     

    -

     

     

    -

     

     

     

    39

     

     

    33

    Admissions

     

    3,326

     

     

    3,393

     

     

     

    12,902

     

     

    13,171

    Average daily census (2)

     

    3,381

     

     

    3,213

     

     

     

    3,415

     

     

    3,279

    Average discharge length of stay

     

    97.8

     

     

    90.2

     

     

     

    94.4

     

     

    87.7

    Patient days

     

    311,015

     

     

    295,619

     

     

     

    1,203,522

     

     

    1,176,193

    Revenue per patient day

    $

    176.01

     

    $

    171.21

     

     

    $

    175.43

     

    $

    171.55

    Organic growth  
    - Revenue

     

    3.5

    %

     

    (4.9

    )%

     

     

    2.0

    %

     

    0.4

    %

    - Average daily census

     

    (1.1

    )%

     

    (0.9

    )%

     

     

    0.3

    %

     

    1.9

    %

       
    Home Health  
       
    Locations served at period end

     

    -

     

     

    -

     

     

     

    24

     

     

    13

    New Admissions

     

    4,654

     

     

    4,081

     

     

     

    16,251

     

     

    14,452

    Recertifications

     

    3,214

     

     

    1,631

     

     

     

    9,030

     

     

    5,838

    Total Volume

     

    7,868

     

     

    5,712

     

     

     

    25,281

     

     

    20,290

    Visits

     

    104,161

     

     

    88,046

     

     

     

    344,919

     

     

    293,381

    Organic growth  
    - Revenue

     

    (17.8

    )%

     

    8.3

    %

     

     

    (7.1

    )%

     

    8.2

    %

    - New admissions

     

    (10.3

    )%

     

    (12.8

    )%

     

     

    (9.8

    )%

     

    16.4

    %

    - Volume

     

    (9.2

    )%

     

    (1.8

    )%

     

     

    (7.2

    )%

     

    18.7

    %

       
    Percentage of Revenues by Payor:  
       
    Personal Care  
       
    State, local and other governmental programs

     

    50.5

    %

     

    49.3

    %

     

     

    50.4

    %

     

    49.3

    %

    Managed care organizations

     

    46.4

     

     

    46.7

     

     

     

    46.2

     

     

    46.3

    Private duty

     

    1.9

     

     

    2.5

     

     

     

    2.0

     

     

    2.6

    Commercial

     

    0.8

     

     

    0.9

     

     

     

    0.8

     

     

    1.1

    Other

     

    0.4

    %

     

    0.6

    %

     

     

    0.6

    %

     

    0.7

    %

       
    Hospice  
       
    Medicare

     

    89.3

    %

     

    91.3

    %

     

     

    89.9

    %

     

    90.9

    %

    Commercial

     

    6.3

     

     

    4.5

     

     

     

    6.0

     

     

    5.0

    Managed care organizations

     

    3.7

     

     

    3.7

     

     

     

    3.4

     

     

    3.6

    Other

     

    0.7

    %

     

    0.5

    %

     

     

    0.7

    %

     

    0.5

    %

       
    Home Health  
       
    Medicare

     

    68.8

    %

     

    74.9

    %

     

     

    72.3

    %

     

    73.5

    %

    Managed care organizations

     

    25.5

     

     

    18.9

     

     

     

    22.2

     

     

    20.3

    Commercial

     

    4.4

     

     

    6.0

     

     

     

    4.4

     

     

    6.0

    Other

     

    1.3

    %

     

    0.2

    %

     

     

    1.1

    %

     

    0.2

    %

       
       
    (1) Exited sites would have reduced same store census for the three and twelve months ended December 31, 2022 by 3 and 24, respectively.
    (2) Exited sites would have reduced average daily census for the three and twelve months ended December 31, 2022 by 6 and 27, respectively.
    ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
    Reconciliation of Non-GAAP Financial Measures
    (Amounts in thousands, except per share data)
    (Unaudited) (1)
     

    For the Three Months
    Ended December 31,

     

    For the Twelve Months
    Ended December 31,

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

    Reconciliation of Adjusted EBITDA to Net Income: (1)
     
    Net income

    $

    19,578

     

    $

    14,762

     

    $

    62,516

     

    $

    46,025

     

     
    Interest expense, net

     

    2,616

     

     

    2,537

     

     

    9,630

     

     

    8,566

     

    (Gain) Loss on sale of assets

     

    3

     

     

    (33

    )

     

    (2

    )

     

    (60

    )

    Income tax expense

     

    5,776

     

     

    3,515

     

     

    18,810

     

     

    14,146

     

    Depreciation and amortization

     

    3,677

     

     

    3,489

     

     

    14,126

     

     

    14,060

     

    Impact of retroactive New York rate increase

     

    -

     

     

    -

     

     

    (868

    )

     

    -

     

    Impact of retroactive collective bargaining negotiations

     

    (1,338

    )

     

    -

     

     

    -

     

     

    -

     

    Acquisition expenses

     

    1,428

     

     

    1,155

     

     

    6,220

     

     

    7,657

     

    Stock-based compensation expense

     

    2,488

     

     

    2,680

     

     

    10,319

     

     

    10,625

     

    Restructure and other non-recurring costs

     

    27

     

     

    143

     

     

    269

     

     

    461

     

    Adjusted EBITDA

    $

    34,255

     

    $

    28,248

     

    $

    121,020

     

    $

    101,480

     

     
     
    Reconciliation of Adjusted Net Income to Net Income: (2)
     
    Net income

    $

    19,578

     

    $

    14,762

     

    $

    62,516

     

    $

    46,025

     

     
    (Gain) Loss on sale of assets

     

    3

     

     

    (33

    )

     

    (2

    )

     

    (60

    )

    Impact of retroactive New York rate increase

     

    -

     

     

    -

     

     

    (868

    )

     

    -

     

    Impact of retroactive collective bargaining negotiations

     

    (1,338

    )

     

    -

     

     

    -

     

     

    -

     

    Acquisition expenses

     

    1,428

     

     

    1,155

     

     

    6,220

     

     

    7,657

     

    Stock-based compensation expense

     

    2,488

     

     

    2,680

     

     

    10,319

     

     

    10,625

     

    Restructure and other non-recurring costs

     

    27

     

     

    143

     

     

    269

     

     

    461

     

    Tax effect

     

    (594

    )

     

    (652

    )

     

    (3,694

    )

     

    (4,393

    )

     
    Adjusted Net Income

    $

    21,592

     

    $

    18,055

     

    $

    74,760

     

    $

    60,315

     

     
     
    Reconciliation of Net Income per Diluted Share to Adjusted Net Income per Diluted Share: (3)
     
    Net income per diluted share

    $

    1.20

     

    $

    0.91

     

    $

    3.83

     

    $

    2.84

     

     
    Impact of retroactive New York rate increase per diluted share

     

    -

     

     

    -

     

     

    (0.04

    )

     

    -

     

    Impact of retroactive collective bargaining negotiations per diluted share

     

    (0.07

    )

     

    -

     

     

    -

     

     

    -

     

    Acquisition expenses per diluted share

     

    0.07

     

     

    0.06

     

     

    0.29

     

     

    0.36

     

    Restructure and other non-recurring costs per diluted share

     

    -

     

     

    0.01

     

     

    0.01

     

     

    0.02

     

    Stock-based compensation expense per diluted share

     

    0.12

     

     

    0.13

     

     

    0.49

     

     

    0.51

     

     
    Adjusted net income per diluted share

    $

    1.32

     

    $

    1.11

     

    $

    4.58

     

    $

    3.73

     

     
    Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (4)
     
    Net service revenues

    $

    276,351

     

    $

    247,050

     

    $

    1,058,651

     

    $

    951,120

     

     
    Revenues associated with the closure of certain sites

     

    (0

    )

     

    (722

    )

     

    (1,325

    )

     

    (4,339

    )

     
    Adjusted net service revenues

    $

    276,351

     

    $

    246,328

     

    $

    1,057,326

     

    $

    946,781

     

    Footnotes:
     
    (1) We define Adjusted EBITDA as earnings before net interest expense, income tax expense, depreciation and amortization, acquisition expenses, stock-based compensation expense, restructure expenses and other non-recurring costs, gain or loss on the sale of assets, retroactive rate increases from New York and the retroactive impact of collective bargaining negotiations. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
    (2) We define Adjusted Net Income as net income before acquisition expenses, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, retroactive rate increases from New York and the retroactive impact of collective bargaining negotiations. Adjusted Net Income is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
    (3) We define Adjusted diluted earnings per share as earnings per share, adjusted for acquisition expenses, stock-based compensation expense and restructure and other non-recurring costs, gain or loss on the sale of asset, retroactive rate increases from New York and the retroactive impact of collective bargaining negotiations. Adjusted diluted earnings per share is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
    (4) We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

     


    The Addus HomeCare Stock at the time of publication of the news with a fall of -1,92 % to 87,39EUR on Nasdaq stock exchange (26. Februar 2024, 21:55 Uhr).


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Addus HomeCare Announces Fourth Quarter and Year End 2023 Financial Results Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2023. Fourth Quarter 2023 Highlights: Net Service Revenues Grow 11.9% to $276.4 …